Abiopharma

Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

BioCardia Announces Henry Ford Health Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial

Tandem Mobi Receives FDA Clearance for Use with Android Smartphones

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025

Press Release: DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

Sonida Senior Living Announces Third Quarter 2025 Results

DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London